arginine has been researched along with Osteoporosis, Postmenopausal in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Miyazaki, A; Nakamura, Y; Nakano, M; Saito, M; Shiraki, M; Suzuki, T; Takahashi, J | 1 |
| Inoue, D; Okazaki, R; Saito, M; Shiraki, M; Watanabe, R | 1 |
| Imai, T; Kashiwabara, S; Saito, M; Shiraki, M; Tanaka, S | 1 |
| Kuroda, T; Saito, M; Shiraki, M; Shiraki, Y; Tanaka, S | 1 |
| Hashidate, H; Ikegami, S; Kamimura, M; Kato, H; Mukaiyama, K; Nakamura, Y; Uchiyama, S | 1 |
| Ikegami, S; Kamimura, M; Kato, H; Mukaiyama, K; Nakamura, Y; Nonaka, K; Uchiyama, S | 1 |
| Arakawa, S; Kida, Y; Marumo, K; Nishizawa, T; Okabe, H; Saito, M; Seki, A | 1 |
| Alacacioglu, A; Aytac, B; Bilgili, S; Gulhan, I; Gunaydin, R; Kebapcilar, L; Kume, T | 1 |
| Baecker, N; Boese, A; Gerzer, R; Heer, M; Schoenau, E | 1 |
| Bellati, U; Liberati, M | 1 |
| De Marco, G; Gangula, P; Wimalawansa, SJ; Yallampalli, C | 1 |
2 trial(s) available for arginine and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
L-arginine, the natural precursor of NO, is not effective for preventing bone loss in postmenopausal women.
Topics: Administration, Oral; Aged; Arginine; Bone Remodeling; Dietary Supplements; Female; Humans; Middle Aged; Nitric Oxide; Osteoporosis, Postmenopausal; Postmenopause | 2005 |
[Experience regarding the use of arginine-lysine-lactose treatment in menopausal osteoporosis].
Topics: Adult; Arginine; Drug Therapy, Combination; Female; Humans; Lactose; Lysine; Middle Aged; Osteoporosis, Postmenopausal | 1994 |
9 other study(ies) available for arginine and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Cohort Studies; Female; Glycation End Products, Advanced; Humans; Japan; Lumbar Vertebrae; Lysine; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause | 2020 |
Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Cohort Studies; Female; Femur Neck; Forced Expiratory Volume; Humans; Kyphosis; Lumbar Vertebrae; Lung; Lysine; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Respiratory Function Tests; Spinal Fractures; Vital Capacity | 2018 |
The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women.
Topics: Aged; Aging; Arginine; Cohort Studies; Cross-Sectional Studies; Female; Humans; Logistic Models; Lysine; Middle Aged; Multivariate Analysis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Prevalence | 2019 |
Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women.
Topics: Aged; Arginine; Body Mass Index; Bone Density; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Japan; Logistic Models; Lysine; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Prevalence; Regression Analysis; Reproducibility of Results; Risk Factors; Spinal Fractures | 2013 |
Serum pentosidine levels after 3 years of bisphosphonate treatment in post-menopausal osteoporotic women.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Bone Density; Diphosphonates; Female; Femur Neck; Humans; Lumbar Vertebrae; Lysine; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Radiography; Treatment Outcome | 2015 |
The skeletal muscle cross sectional area in long-term bisphosphonate users is smaller than that of bone mineral density-matched controls with increased serum pentosidine concentrations.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Arginine; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cross-Sectional Studies; Diphosphonates; Female; Humans; Lysine; Middle Aged; Muscle, Skeletal; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed | 2015 |
Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys.
Topics: Animals; Arginine; Bone Density; Bone Density Conservation Agents; Collagen; Cross-Linking Reagents; Disease Models, Animal; Female; Glycation End Products, Advanced; Humans; Indoles; Lumbar Vertebrae; Lysine; Macaca fascicularis; Osteoporosis, Postmenopausal; Ovariectomy; Selective Estrogen Receptor Modulators; X-Ray Microtomography | 2015 |
Postmenopausal women with osteoporosis may be associated with high endothelin-1.
Topics: Arginine; Bone Density; Chi-Square Distribution; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Regression Analysis | 2009 |
Nitric oxide donor alleviates ovariectomy-induced bone loss.
Topics: Absorptiometry, Photon; Analysis of Variance; Animals; Arginine; Bone Density; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroglycerin; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley | 1996 |